Abstract:Four-membered heterocycles such as oxetanes and azetidines represent attractive and emergent design options in medicinal chemistry due to their small and polar nature, and potential to significantly impact physiochemical properties of drug molecules. The challenging preparation of these derivatives, especially in a divergent manner, has severely limited the combination of oxetanes with other medicinally and biologically important groups. Consequently, there is a substantial demand for mild and effective synthetic strategies to access new oxetane and azetidine derivatives and molecular scaffolds. Herein, we report the development and use of oxetane sulfonyl fluorides (OSF) and azetidine sulfonyl fluorides (ASF), which behave as precursors to carbocations in an unusual defluorosulfonylation reaction pathway (deFS). The small-ring sulfonyl fluorides are activated under mild thermal conditions (60 ºC), and the generated reactive intermediates couple with a broad range of nucleophiles. This reactivity enables the generation of new chemical motifs that make attractive design elements for drug discovery. Notably, oxetane and azetidine-heterocyclic, -sulfoximine and -phosphonate derivatives are prepared, several of which do not have comparable carbonyl analogues. Alternatively, a SuFEx pathway under anionic conditions accesses oxetane-sulfur (VI) derivatives. We demonstrate the synthetic utility of novel OSF and ASF reagents through the synthesis of 11 drug analogues, showcasing their potential for subsequent diversification and facile inclusion into medicinal chemistry programs. Moreover, we propose the application of the OSF and ASF reagents as linker motifs and demonstrate the incorporation of pendant groups suitable for common conjugation reactions. Productive deFS reactions with E3 ligase recruiters such as pomalidomide and related derivatives provide new degrader motifs, and potential PROTAC linkers.

Unveiling sultam in drug discovery: spotlight on the underexplored scaffold

Recent developments of synthesis and biological activity of sultone scaffolds in medicinal chemistry

Advances in Computational Structure-Based Drug Design and Application in Drug Discovery.

Scaffold hopping approaches for dual-target antitumor drug discovery: opportunities and challenges

Harnessing Oxetane and Azetidine Sulfonyl Fluorides for Opportunities in Drug Discovery

The importance of sulfur-containing motifs in drug design and discovery

An overview of spirooxindole as a promising scaffold for novel drug discovery

Neglected sulfur(VI) pharmacophores in drug discovery: exploration of novel chemical space by the interplay of drug design and method development

Streamlining SuFEx Inhibitor Development: A Unified Approach Using Orthogonal Sulfinate Protecting Groups

Scaffold-Induced Molecular Graph (SIMG): Effective Graph Sampling Methods for High-Throughput Computational Drug Discovery

Phenoxyalkyl cyclic and acyclic amine derivatives: what do they teach us about scaffold-based drug design?

Pyridine: the scaffolds with significant clinical diversity

Imidazopyrimidine: from a relatively exotic scaffold to an evolving structural motif in drug discovery

Discovery of Novel Succinate Dehydrogenase Inhibitors by the Integration of in Silico Library Design and Pharmacophore Mapping.

Benzimidazole as a Privileged Scaffold in Drug Design and Discovery

Thiazole moiety: A promising scaffold for anticancer drug discovery

Pyrrolotriazinone as an Underexplored Scaffold in Drug Discovery

The Vinyl Sulfone Motif As a Structural Unit for Novel Drug Design and Discovery

Targeting disease with benzoxazoles: a comprehensive review of recent developments

A Profound Insight into the Structure-activity Relationship of Ubiquitous Scaffold Piperazine: An Explicative Review